vs
欧加隆（OGN）与SCANSOURCE, INC.（SCSC）财务数据对比。点击上方公司名可切换其他公司
欧加隆的季度营收约是SCANSOURCE, INC.的2.0倍（$1.5B vs $766.5M），SCANSOURCE, INC.净利率更高（2.2% vs -13.6%，领先15.8%），SCANSOURCE, INC.同比增速更快（2.5% vs -5.3%），欧加隆自由现金流更多（$96.0M vs $28.9M），过去两年SCANSOURCE, INC.的营收复合增速更高（0.9% vs -3.6%）
欧加隆是一家总部位于美国新泽西州泽西城的制药企业，核心业务覆盖生殖医学、避孕、精神科、激素替代疗法及麻醉领域的药物研发与生产。公司所有产品均在美国境外生产，同时美国市场贡献了其三分之一的营收。
ScanSource是全球领先的专业技术分销商，主营销售点系统、条码扫描设备、网络安全产品、云服务及通信解决方案，面向北美、拉美、欧洲的增值经销商、服务提供商及企业客户，覆盖零售、医疗、工业、公共部门等领域。
OGN vs SCSC — 直观对比
营收规模更大
OGN
是对方的2.0倍
$766.5M
营收增速更快
SCSC
高出7.9%
-5.3%
净利率更高
SCSC
高出15.8%
-13.6%
自由现金流更多
OGN
多$67.1M
$28.9M
两年增速更快
SCSC
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $766.5M |
| 净利润 | $-205.0M | $16.5M |
| 毛利率 | 49.2% | 13.4% |
| 营业利润率 | -9.8% | 2.3% |
| 净利率 | -13.6% | 2.2% |
| 营收同比 | -5.3% | 2.5% |
| 净利润同比 | -288.1% | -3.3% |
| 每股收益（稀释后） | $-0.78 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OGNSCSC
| Q4 25 | $1.5B | $766.5M | ||
| Q3 25 | $1.6B | $739.6M | ||
| Q2 25 | $1.6B | $812.9M | ||
| Q1 25 | $1.5B | $704.8M | ||
| Q4 24 | $1.6B | $747.5M | ||
| Q3 24 | $1.6B | $775.6M | ||
| Q2 24 | $1.6B | $746.1M | ||
| Q1 24 | $1.6B | $752.6M |
净利润OGNSCSC
| Q4 25 | $-205.0M | $16.5M | ||
| Q3 25 | $160.0M | $19.9M | ||
| Q2 25 | $145.0M | $20.1M | ||
| Q1 25 | $87.0M | $17.4M | ||
| Q4 24 | $109.0M | $17.1M | ||
| Q3 24 | $359.0M | $17.0M | ||
| Q2 24 | $195.0M | $16.1M | ||
| Q1 24 | $201.0M | $12.8M |
毛利率OGNSCSC
| Q4 25 | 49.2% | 13.4% | ||
| Q3 25 | 53.5% | 14.5% | ||
| Q2 25 | 54.8% | 12.9% | ||
| Q1 25 | 55.6% | 14.2% | ||
| Q4 24 | 56.3% | 13.6% | ||
| Q3 24 | 58.3% | 13.1% | ||
| Q2 24 | 58.4% | 13.0% | ||
| Q1 24 | 59.0% | 12.6% |
营业利润率OGNSCSC
| Q4 25 | -9.8% | 2.3% | ||
| Q3 25 | 15.2% | 3.5% | ||
| Q2 25 | 14.4% | 3.3% | ||
| Q1 25 | 6.7% | 3.2% | ||
| Q4 24 | 8.1% | 2.5% | ||
| Q3 24 | 13.1% | 2.3% | ||
| Q2 24 | 14.6% | 2.9% | ||
| Q1 24 | 14.5% | 2.3% |
净利率OGNSCSC
| Q4 25 | -13.6% | 2.2% | ||
| Q3 25 | 10.0% | 2.7% | ||
| Q2 25 | 9.1% | 2.5% | ||
| Q1 25 | 5.8% | 2.5% | ||
| Q4 24 | 6.8% | 2.3% | ||
| Q3 24 | 22.7% | 2.2% | ||
| Q2 24 | 12.1% | 2.2% | ||
| Q1 24 | 12.4% | 1.7% |
每股收益（稀释后）OGNSCSC
| Q4 25 | $-0.78 | $0.75 | ||
| Q3 25 | $0.61 | $0.89 | ||
| Q2 25 | $0.56 | $0.87 | ||
| Q1 25 | $0.33 | $0.74 | ||
| Q4 24 | $0.42 | $0.70 | ||
| Q3 24 | $1.38 | $0.69 | ||
| Q2 24 | $0.75 | $0.66 | ||
| Q1 24 | $0.78 | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $574.0M | $83.5M |
| 总债务越低越好 | $8.6B | — |
| 股东权益账面价值 | $752.0M | $910.9M |
| 总资产 | $12.9B | $1.7B |
| 负债/权益比越低杠杆越低 | 11.49× | — |
8季度趋势，按日历期对齐
现金及短期投资OGNSCSC
| Q4 25 | $574.0M | $83.5M | ||
| Q3 25 | $672.0M | $124.9M | ||
| Q2 25 | $599.0M | $126.2M | ||
| Q1 25 | $547.0M | $146.3M | ||
| Q4 24 | $675.0M | $110.5M | ||
| Q3 24 | $763.0M | $145.0M | ||
| Q2 24 | $704.0M | $185.5M | ||
| Q1 24 | $575.0M | $159.1M |
总债务OGNSCSC
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
股东权益OGNSCSC
| Q4 25 | $752.0M | $910.9M | ||
| Q3 25 | $906.0M | $914.0M | ||
| Q2 25 | $733.0M | $906.4M | ||
| Q1 25 | $542.0M | $901.7M | ||
| Q4 24 | $472.0M | $900.7M | ||
| Q3 24 | $493.0M | $920.9M | ||
| Q2 24 | $144.0M | $924.3M | ||
| Q1 24 | $48.0M | $944.1M |
总资产OGNSCSC
| Q4 25 | $12.9B | $1.7B | ||
| Q3 25 | $13.6B | $1.7B | ||
| Q2 25 | $13.5B | $1.8B | ||
| Q1 25 | $13.2B | $1.7B | ||
| Q4 24 | $13.1B | $1.7B | ||
| Q3 24 | $12.8B | $1.8B | ||
| Q2 24 | $12.2B | $1.8B | ||
| Q1 24 | $11.9B | $1.8B |
负债/权益比OGNSCSC
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.0M | $30.8M |
| 自由现金流经营现金流 - 资本支出 | $96.0M | $28.9M |
| 自由现金流率自由现金流/营收 | 6.4% | 3.8% |
| 资本支出强度资本支出/营收 | 3.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 1.87× |
| 过去12个月自由现金流最近4个季度 | $538.0M | — |
8季度趋势，按日历期对齐
经营现金流OGNSCSC
| Q4 25 | $141.0M | $30.8M | ||
| Q3 25 | $264.0M | $23.2M | ||
| Q2 25 | $220.0M | — | ||
| Q1 25 | $75.0M | $66.1M | ||
| Q4 24 | $390.0M | $-6.2M | ||
| Q3 24 | $141.0M | $44.8M | ||
| Q2 24 | $332.0M | — | ||
| Q1 24 | $76.0M | $160.2M |
自由现金流OGNSCSC
| Q4 25 | $96.0M | $28.9M | ||
| Q3 25 | $218.0M | $20.8M | ||
| Q2 25 | $181.0M | — | ||
| Q1 25 | $43.0M | $64.6M | ||
| Q4 24 | $335.0M | $-8.2M | ||
| Q3 24 | $99.0M | $42.5M | ||
| Q2 24 | $300.0M | — | ||
| Q1 24 | $30.0M | $157.7M |
自由现金流率OGNSCSC
| Q4 25 | 6.4% | 3.8% | ||
| Q3 25 | 13.6% | 2.8% | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 2.8% | 9.2% | ||
| Q4 24 | 21.0% | -1.1% | ||
| Q3 24 | 6.3% | 5.5% | ||
| Q2 24 | 18.7% | — | ||
| Q1 24 | 1.8% | 21.0% |
资本支出强度OGNSCSC
| Q4 25 | 3.0% | 0.3% | ||
| Q3 25 | 2.9% | 0.3% | ||
| Q2 25 | 2.4% | 0.3% | ||
| Q1 25 | 2.1% | 0.2% | ||
| Q4 24 | 3.5% | 0.3% | ||
| Q3 24 | 2.7% | 0.3% | ||
| Q2 24 | 2.0% | 0.2% | ||
| Q1 24 | 2.8% | 0.3% |
现金转化率OGNSCSC
| Q4 25 | — | 1.87× | ||
| Q3 25 | 1.65× | 1.17× | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 0.86× | 3.79× | ||
| Q4 24 | 3.58× | -0.36× | ||
| Q3 24 | 0.39× | 2.64× | ||
| Q2 24 | 1.70× | — | ||
| Q1 24 | 0.38× | 12.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OGN
暂无分部数据
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
